Skip to main content
Erschienen in: Obesity Surgery 2/2020

24.10.2019 | Original Contributions

Genetic Obesity and Bariatric Surgery Outcome in 1014 Patients with Morbid Obesity

verfasst von: M.I. Cooiman, L. Kleinendorst, E.O. Aarts, I.M.C. Janssen, H.K. Ploos van Amstel, A.I. Blakemore, E.J. Hazebroek, H.J. Meijers-Heijboer, B. van der Zwaag, F.J. Berends, M.M. van Haelst

Erschienen in: Obesity Surgery | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

Mutations in the leptin-melanocortin pathway genes are known to cause monogenic obesity. The prevalence of these gene mutations and their effect on weight loss response after bariatric surgery are still largely unknown.

Objective

To determine the prevalence of genetic obesity in a large bariatric cohort and evaluate their response to bariatric surgery.

Methods

Mutation analysis of 52 obesity-associated genes. Patient inclusion criteria were a BMI > 50 kg/m2, an indication for revisional surgery or an early onset of obesity (< 10 years of age).

Results

A total of 1014 patients were included, of whom 30 (3%) were diagnosed with genetic obesity, caused by pathogenic heterozygous mutations in either MC4R, POMC, PCSK1, SIM1, or PTEN. The percentage total body weight loss (%TBWL) after Roux-en-Y gastric bypass (RYGB) surgery was not significantly different for patients with a mutation in MC4R, POMC, and PCSK1 compared with patients lacking a molecular diagnosis. Of the confirmed genetic obesity cases, only patients with MC4R mutations receiving a sleeve gastrectomy (SG) showed significantly lower %TBWL compared with patients lacking a molecular diagnosis, during 2 years of follow-up.

Conclusions

In this cohort of morbid obese bariatric patients, an estimated prevalence of monogenic obesity of 3% is reported. Among these patients, the clinical effects of heterozygous mutations in POMC and PCSK1 do not interfere with the effectiveness of most commonly performed bariatric procedures within the first 2 years of follow-up. Patients with MC4R mutations achieved superior weight loss after primary RYGB compared with SG.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Klaauw van der AA, Farooqi IS. The hunger genes: pathways to obesity. Cell. 2015;161:119–32.CrossRef Klaauw van der AA, Farooqi IS. The hunger genes: pathways to obesity. Cell. 2015;161:119–32.CrossRef
2.
Zurück zum Zitat Mountjoy KG, Mortrud MT, Low MJ, et al. Localisation of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol Endocrinol. 1994;8:1298–308.PubMed Mountjoy KG, Mortrud MT, Low MJ, et al. Localisation of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol Endocrinol. 1994;8:1298–308.PubMed
3.
Zurück zum Zitat Farooqi IS, O’Rahilly S. 20 years of leptin: human disorders of leptin action. J Endocrinol. 2014;223(1):63–70.CrossRef Farooqi IS, O’Rahilly S. 20 years of leptin: human disorders of leptin action. J Endocrinol. 2014;223(1):63–70.CrossRef
4.
Zurück zum Zitat Farooqi IS, O’Rahilly S. Mutations in ligands and receptor of the leptin-melanocortin pathway that lead to obesity. Endocrinol Metab. 2008;4(10):569–77. Farooqi IS, O’Rahilly S. Mutations in ligands and receptor of the leptin-melanocortin pathway that lead to obesity. Endocrinol Metab. 2008;4(10):569–77.
6.
Zurück zum Zitat Roux CW le , Heneghan HM. Bariatric surgery for obesity. Med Clin N Am 2018;108;165–182. Roux CW le , Heneghan HM. Bariatric surgery for obesity. Med Clin N Am 2018;108;165–182.
7.
Zurück zum Zitat Dogan K, Betzel B, Homan J, et al. Long-term effect of laparoscopic Roux-en-Y gastric bypass on diabetes mellitus, hypertension and dyslipidaemia in morbidly obese patients. Obes Surg. 2014;24:1835–42.CrossRefPubMed Dogan K, Betzel B, Homan J, et al. Long-term effect of laparoscopic Roux-en-Y gastric bypass on diabetes mellitus, hypertension and dyslipidaemia in morbidly obese patients. Obes Surg. 2014;24:1835–42.CrossRefPubMed
9.
Zurück zum Zitat Felsenreich DM, Langer FB, Kefurt R. Weight loss, weight regain and conversions to Roux-en-Y gastric bypass: 10 year results of laparoscopic sleeve gastrectomy. Surg Obes Relat Dis. 2016;12(9):1655–62.CrossRefPubMed Felsenreich DM, Langer FB, Kefurt R. Weight loss, weight regain and conversions to Roux-en-Y gastric bypass: 10 year results of laparoscopic sleeve gastrectomy. Surg Obes Relat Dis. 2016;12(9):1655–62.CrossRefPubMed
11.
Zurück zum Zitat Censani M, Conroy R, Deng L, et al. Weight loss after bariatric surgery in morbidly obese adolescents with MC4R mutations. Obesity. 2014;22(1):225–31.CrossRefPubMed Censani M, Conroy R, Deng L, et al. Weight loss after bariatric surgery in morbidly obese adolescents with MC4R mutations. Obesity. 2014;22(1):225–31.CrossRefPubMed
12.
Zurück zum Zitat Aslan YR, Campos GM, Calton MA, et al. Weight loss after Roux-en-Y gastric bypass in obese patients heterozygous for MC4R mutations. Obes Surg. 2011;21:930–4.CrossRefPubMed Aslan YR, Campos GM, Calton MA, et al. Weight loss after Roux-en-Y gastric bypass in obese patients heterozygous for MC4R mutations. Obes Surg. 2011;21:930–4.CrossRefPubMed
13.
Zurück zum Zitat Valette M, Poitou C, Le Beyec J, et al. Melanocortin-4 receptor mutations and polymorphisms do not affect weight loss after bariatric surgery. PLoS One. 2012;7(11):e48221.CrossRefPubMedPubMedCentral Valette M, Poitou C, Le Beyec J, et al. Melanocortin-4 receptor mutations and polymorphisms do not affect weight loss after bariatric surgery. PLoS One. 2012;7(11):e48221.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Farooqi IS, Keogh JM, Yeo GS, et al. Clinical spectrum of obesity and mutations in the melanocortin-4-receptor gene. N Engl J Med. 2003;348:1085–95.CrossRefPubMed Farooqi IS, Keogh JM, Yeo GS, et al. Clinical spectrum of obesity and mutations in the melanocortin-4-receptor gene. N Engl J Med. 2003;348:1085–95.CrossRefPubMed
21.
Zurück zum Zitat Stutzmann F, Tan K, Vatin V, et al. Prevalence of melanocortin-4 receptor deficiency in Europeans and their age-dependent penetrance in multigenerational pedigrees. Diabetes. 2008;57:2511–8.CrossRefPubMedPubMedCentral Stutzmann F, Tan K, Vatin V, et al. Prevalence of melanocortin-4 receptor deficiency in Europeans and their age-dependent penetrance in multigenerational pedigrees. Diabetes. 2008;57:2511–8.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Hatoum IJ, Stylopoulos N, Vanhoose AM, et al. Melanocortin-4 receptor signaling is required for weight loss after gastric bypass surgery. J Clin Endocrinol Metab. 2012;97:1023–31.CrossRef Hatoum IJ, Stylopoulos N, Vanhoose AM, et al. Melanocortin-4 receptor signaling is required for weight loss after gastric bypass surgery. J Clin Endocrinol Metab. 2012;97:1023–31.CrossRef
23.
Zurück zum Zitat Lubrano-Berthelier C, Dubern B, Lacorte JM, et al. Melancortin 4 receptor mutations in a large cohort of severely obese adults: prevalence, functional classification, genotype-phenotype relationship and lack of association with binge eating. J Clin Endocrinol Metab. 2006;91(5):1811–8.CrossRefPubMed Lubrano-Berthelier C, Dubern B, Lacorte JM, et al. Melancortin 4 receptor mutations in a large cohort of severely obese adults: prevalence, functional classification, genotype-phenotype relationship and lack of association with binge eating. J Clin Endocrinol Metab. 2006;91(5):1811–8.CrossRefPubMed
24.
Zurück zum Zitat Miraglia del Guidice E, Cirillo G, Nigro V, et al. Low frequency of melanocortin-4 receptor (MC4R) mutations in a Mediterranean population with early-onset obesity. Int J Obes. 2002;26:647–51.CrossRef Miraglia del Guidice E, Cirillo G, Nigro V, et al. Low frequency of melanocortin-4 receptor (MC4R) mutations in a Mediterranean population with early-onset obesity. Int J Obes. 2002;26:647–51.CrossRef
25.
Zurück zum Zitat Challis BG, Pritchard LE, Creemers JWM, et al. A missense mutation disrupting a dibasic prohormone processing site in pro-opiomelanocortin(POMC) increases susceptibility to early-onset obesity through a novel molecular mechanism. Hum Mol Genet. 2002;11(17):1997–2004.CrossRefPubMed Challis BG, Pritchard LE, Creemers JWM, et al. A missense mutation disrupting a dibasic prohormone processing site in pro-opiomelanocortin(POMC) increases susceptibility to early-onset obesity through a novel molecular mechanism. Hum Mol Genet. 2002;11(17):1997–2004.CrossRefPubMed
26.
Zurück zum Zitat Philippe J, Stijnen P, Meyre D, et al. A nonsense loss-of-function mutation in PCSK1 contributes to dominantly inherited human obesity. Int J Obes. 2015;39:295–302.CrossRef Philippe J, Stijnen P, Meyre D, et al. A nonsense loss-of-function mutation in PCSK1 contributes to dominantly inherited human obesity. Int J Obes. 2015;39:295–302.CrossRef
27.
Zurück zum Zitat Creemers JWM, Choquet H, Stijnen P, et al. Heterozygous mutations causing partial prohormone convertase 1 deficiency contribute to human obesity. Diabetes. 2012;61:383–90.CrossRefPubMedPubMedCentral Creemers JWM, Choquet H, Stijnen P, et al. Heterozygous mutations causing partial prohormone convertase 1 deficiency contribute to human obesity. Diabetes. 2012;61:383–90.CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Elkhenini HF, New JP, Syed AA. Five-year outcome of bariatric surgery in a patient with melanocortin-4 receptor mutation. Clin Obes. 2014;4:121–4.CrossRefPubMed Elkhenini HF, New JP, Syed AA. Five-year outcome of bariatric surgery in a patient with melanocortin-4 receptor mutation. Clin Obes. 2014;4:121–4.CrossRefPubMed
31.
Zurück zum Zitat Locke AE, Kahali B, Berndt SI, et al. Genetic studies of body mass index yield new insights for obesity biology. Nature. 2015;518(7538):197–206.CrossRefPubMedPubMedCentral Locke AE, Kahali B, Berndt SI, et al. Genetic studies of body mass index yield new insights for obesity biology. Nature. 2015;518(7538):197–206.CrossRefPubMedPubMedCentral
Metadaten
Titel
Genetic Obesity and Bariatric Surgery Outcome in 1014 Patients with Morbid Obesity
verfasst von
M.I. Cooiman
L. Kleinendorst
E.O. Aarts
I.M.C. Janssen
H.K. Ploos van Amstel
A.I. Blakemore
E.J. Hazebroek
H.J. Meijers-Heijboer
B. van der Zwaag
F.J. Berends
M.M. van Haelst
Publikationsdatum
24.10.2019
Verlag
Springer US
Erschienen in
Obesity Surgery / Ausgabe 2/2020
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-019-04184-w

Weitere Artikel der Ausgabe 2/2020

Obesity Surgery 2/2020 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.